drugset / Trial / NCT02175238
Relative Bioavailability of BI 691751 Administered With and Without Food to Healthy Male Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
The primary objective of this trial is to investigate the relative bioavailability and pharmacokinetics in plasma and whole blood of BI 691751 administered as a single dose with and without food in healthy male subjects.
Timeline
- Start
- 2014-07
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BI 691751 | Unknown | — | — |
Indications
No indication recorded.